|
OMIM |
Link |
Information gain |
01 |
|
SCZD7
|
[NCBI]
|
0.00126193
|
|
|
coronary heart disease, susceptibility to, 3
|
[NCBI]
|
0.0010811
|
|
|
thyroid carcinoma, papillary, with papillary renal neoplasia
|
[NCBI]
|
0.000816549
|
|
|
malaria, mild, susceptibility to
|
[NCBI]
|
0.000816549
|
|
|
NNCI
|
[NCBI]
|
0.000816549
|
|
|
astigmatism
|
[NCBI]
|
0.000717105
|
|
|
OPA2
|
[NCBI]
|
0.000717105
|
|
|
PEE1
|
[NCBI]
|
0.000683909
|
|
|
epilepsy, nocturnal frontal lobe, type 2
|
[NCBI]
|
0.000652758
|
|
|
ICCA
|
[NCBI]
|
0.000652758
|
|
|
SCZD5
|
[NCBI]
|
0.000652758
|
|
|
prognathism, mandibular
|
[NCBI]
|
0.000652758
|
|
|
coronary heart disease, susceptibility to, 2
|
[NCBI]
|
0.00060508
|
|
|
IBD3
|
[NCBI]
|
0.00060508
|
|
|
OFC1
|
[NCBI]
|
0.000572824
|
|
|
panbronchiolitis, diffuse
|
[NCBI]
|
0.000567219
|
|
|
beta-aminoisobutyric acid, urinary excretion of
|
[NCBI]
|
0.000535846
|
|
|
prostate cancer, hereditary, 8
|
[NCBI]
|
0.000509083
|
|
|
IGES
|
[NCBI]
|
0.000485768
|
|
|
microcephalic osteodysplastic primordial dwarfism, type i
|
[NCBI]
|
0.000465128
|
|
|
MAFD1
|
[NCBI]
|
0.000421818
|
|
|
IDDM4
|
[NCBI]
|
0.000414573
|
|
|
ATHS
|
[NCBI]
|
0.000353486
|
|
|
IDDM
|
[NCBI]
|
0.000301679
|
|
|
diabetes mellitus, insulin-dependent, 2
|
[NCBI]
|
0.000273628
|
|
|
CMM
|
[NCBI]
|
0.000169534
|
|
|
prostate cancer
|
[NCBI]
|
0.000164882
|
|
|
hemoglobin, high oxygen saturation of
|
[NCBI]
|
0.000133816
|
|
|
folate level in erythrocytes
|
[NCBI]
|
0.000133816
|
|
|
SLE
|
[NCBI]
|
0.000126916
|
|
|
urticaria, familial localized heat
|
[NCBI]
|
0.000106067
|
|
|
periodontitis, chronic
|
[NCBI]
|
0.000106067
|
|
|
RA
|
[NCBI]
|
0.000101685
|
|
|
cataract, age-related nuclear
|
[NCBI]
|
9.56087e-05
|
|
|
urticaria, aquagenic
|
[NCBI]
|
9.56087e-05
|
|
|
epilepsy, nocturnal frontal lobe, type 3
|
[NCBI]
|
9.56087e-05
|
|
|
DDU
|
[NCBI]
|
9.56087e-05
|
|
|
bilirubin, elevated concentrations of, in serum
|
[NCBI]
|
8.8826e-05
|
|
|
polydactyly, preaxial i
|
[NCBI]
|
8.8826e-05
|
|
|
lactase deficiency, congenital
|
[NCBI]
|
8.8826e-05
|
|
|
cardiomyopathy, dilated, autosomal recessive
|
[NCBI]
|
8.8826e-05
|
|
|
EBN2
|
[NCBI]
|
8.8826e-05
|
|
|
asthma, susceptibility to
|
[NCBI]
|
8.87166e-05
|
|
|
seizures, benign familial neonatal-infantile
|
[NCBI]
|
8.37889e-05
|
|
|
mental retardation, fra12a type
|
[NCBI]
|
7.97799e-05
|
|
|
hypospadias, autosomal
|
[NCBI]
|
7.64502e-05
|
|
|
mast cell disease
|
[NCBI]
|
7.36033e-05
|
|
|
epilepsy, nocturnal frontal lobe, type 1
|
[NCBI]
|
7.36033e-05
|
|
|
SCZD
|
[NCBI]
|
7.34876e-05
|
|
|
NIDDM1
|
[NCBI]
|
7.11175e-05
|
|
|
tobacco addiction, susceptibility to
|
[NCBI]
|
7.11175e-05
|
|
|
NYS1
|
[NCBI]
|
6.89119e-05
|
|
|
SCZD9
|
[NCBI]
|
6.19673e-05
|
|
|
amyotrophic lateral sclerosis-parkinsonism/dementia complex 1
|
[NCBI]
|
6.19673e-05
|
|
|
muckle-wells syndrome
|
[NCBI]
|
6.05601e-05
|
|
|
periodontitis, aggressive, 1
|
[NCBI]
|
5.80206e-05
|
|
|
HPC1
|
[NCBI]
|
5.80206e-05
|
|
|
GEFS+
|
[NCBI]
|
5.57779e-05
|
|
|
EBN1
|
[NCBI]
|
5.57779e-05
|
|
|
GLC3A
|
[NCBI]
|
5.3771e-05
|
|
|
hodgkin lymphoma
|
[NCBI]
|
5.19557e-05
|
|
|
CDKN2A
|
[NCBI]
|
5.13806e-05
|
|
|
CMM2
|
[NCBI]
|
5.11094e-05
|
|
|
alcohol dependence
|
[NCBI]
|
5.11094e-05
|
|
|
AD
|
[NCBI]
|
5.06662e-05
|
|
|
osteoarthritis
|
[NCBI]
|
4.9523e-05
|
|
|
LCA1
|
[NCBI]
|
4.9523e-05
|
|
|
usher syndrome, type i
|
[NCBI]
|
4.80601e-05
|
|
|
alzheimer disease 3
|
[NCBI]
|
4.73695e-05
|
|
|
exostoses, multiple, type i
|
[NCBI]
|
4.60607e-05
|
|
|
FCHL
|
[NCBI]
|
4.54394e-05
|
|
|
APOBEC4
|
[NCBI]
|
4.52576e-05
|
|
|
CALML6
|
[NCBI]
|
4.52576e-05
|
|
|
APOB
|
[NCBI]
|
4.50803e-05
|
|
|
FCAS
|
[NCBI]
|
4.36919e-05
|
|
|
malaria, susceptibility to
|
[NCBI]
|
4.31444e-05
|
|
|
lactase persistence
|
[NCBI]
|
4.26129e-05
|
|
|
IGER
|
[NCBI]
|
4.06297e-05
|
|
|
LI1
|
[NCBI]
|
3.97141e-05
|
|
|
VMD
|
[NCBI]
|
3.97141e-05
|
|
|
SCIDX1
|
[NCBI]
|
3.88429e-05
|
|
|
DYT1
|
[NCBI]
|
3.88429e-05
|
|
|
obesity
|
[NCBI]
|
3.72186e-05
|
|
|
OR13G1
|
[NCBI]
|
3.70129e-05
|
|
|
DIP2C
|
[NCBI]
|
3.70129e-05
|
|
|
SEMG2
|
[NCBI]
|
3.70129e-05
|
|
|
DIP2B
|
[NCBI]
|
3.70129e-05
|
|
|
TAS2R50
|
[NCBI]
|
3.70129e-05
|
|
|
HRG
|
[NCBI]
|
3.47158e-05
|
|
|
AT
|
[NCBI]
|
3.45445e-05
|
|
|
ARMD1
|
[NCBI]
|
3.43603e-05
|
|
|
DIP2A
|
[NCBI]
|
3.39029e-05
|
|
|
MIRN196B
|
[NCBI]
|
3.39029e-05
|
|
|
SPRN
|
[NCBI]
|
3.39029e-05
|
|
|
C14ORF173
|
[NCBI]
|
3.39029e-05
|
|
|
CYP2C18
|
[NCBI]
|
3.39029e-05
|
|
|
MIRN10B
|
[NCBI]
|
3.39029e-05
|
|
|
MIRN196A2
|
[NCBI]
|
3.39029e-05
|
|
|
temporal arteritis
|
[NCBI]
|
3.31627e-05
|
|
|
CHH
|
[NCBI]
|
3.27868e-05
|
|
|
AS
|
[NCBI]
|
3.22471e-05
|
|
|
IL1R2
|
[NCBI]
|
3.18842e-05
|
|
|
ULBP1
|
[NCBI]
|
3.18842e-05
|
|
|
CMT1A
|
[NCBI]
|
3.16246e-05
|
|
|
hypertension, essential
|
[NCBI]
|
3.10722e-05
|
|
|
MIRN196A1
|
[NCBI]
|
3.03839e-05
|
|
|
CFH
|
[NCBI]
|
3.01051e-05
|
|
|
APOE
|
[NCBI]
|
2.99502e-05
|
|
|
CHRNB4
|
[NCBI]
|
2.91889e-05
|
|
|
g72 gene
|
[NCBI]
|
2.91889e-05
|
|
|
PSORS1
|
[NCBI]
|
2.90288e-05
|
|
|
BRCA2
|
[NCBI]
|
2.88533e-05
|
|
|
DDC
|
[NCBI]
|
2.86855e-05
|
|
|
PALLD
|
[NCBI]
|
2.81957e-05
|
|
|
FBXO15
|
[NCBI]
|
2.81957e-05
|
|
|
ROS1
|
[NCBI]
|
2.73458e-05
|
|
|
RMRP
|
[NCBI]
|
2.43186e-05
|
|
|
ADHD
|
[NCBI]
|
2.4278e-05
|
|
|
HD
|
[NCBI]
|
2.42703e-05
|
|
|
NQO1
|
[NCBI]
|
2.38634e-05
|
|
|
SCN2A
|
[NCBI]
|
2.3441e-05
|
|
|
MC3R
|
[NCBI]
|
2.26779e-05
|
|
|
KEAP1
|
[NCBI]
|
2.26779e-05
|
|
|
BRCA1
|
[NCBI]
|
2.25872e-05
|
|
|
MS
|
[NCBI]
|
2.22759e-05
|
|
|
GUCY2D
|
[NCBI]
|
2.16926e-05
|
|
|
AFP
|
[NCBI]
|
2.16593e-05
|
|
|
CYCS
|
[NCBI]
|
2.08499e-05
|
|
|
RHD
|
[NCBI]
|
2.05941e-05
|
|
|
HSR
|
[NCBI]
|
2.03491e-05
|
|
|
CRP
|
[NCBI]
|
2.0114e-05
|
|
|
ETS1
|
[NCBI]
|
1.98881e-05
|
|
|
HTR2A
|
[NCBI]
|
1.98881e-05
|
|
|
HSCR1
|
[NCBI]
|
1.97042e-05
|
|
|
LFNG
|
[NCBI]
|
1.92588e-05
|
|
|
PMD
|
[NCBI]
|
1.90649e-05
|
|
|
NOS2A
|
[NCBI]
|
1.90634e-05
|
|
|
MYO7A
|
[NCBI]
|
1.78547e-05
|
|
|
KLK3
|
[NCBI]
|
1.77488e-05
|
|
|
LTA
|
[NCBI]
|
1.77011e-05
|
|
|
ABO
|
[NCBI]
|
1.75514e-05
|
|
|
ADIPOQ
|
[NCBI]
|
1.6857e-05
|
|
|
SOX9
|
[NCBI]
|
1.67277e-05
|
|
|
factor x deficiency
|
[NCBI]
|
1.63567e-05
|
|
|
RP2
|
[NCBI]
|
1.60084e-05
|
|
|
DFSP
|
[NCBI]
|
1.58547e-05
|
|
|
MSH2
|
[NCBI]
|
1.54719e-05
|
|
|
A2M
|
[NCBI]
|
1.53705e-05
|
|
|
NAT1
|
[NCBI]
|
1.52708e-05
|
|
|
EGF
|
[NCBI]
|
1.5012e-05
|
|
|
SLC11A1
|
[NCBI]
|
1.49821e-05
|
|
|
NOS3
|
[NCBI]
|
1.48891e-05
|
|
|
DGS
|
[NCBI]
|
1.48186e-05
|
|
|
leber optic atrophy
|
[NCBI]
|
1.4375e-05
|
|
|
CCR5
|
[NCBI]
|
1.41152e-05
|
|
|
DRD4
|
[NCBI]
|
1.3957e-05
|
|
|
IL3
|
[NCBI]
|
1.38031e-05
|
|
|
MLH1
|
[NCBI]
|
1.36535e-05
|
|
|
CPI
|
[NCBI]
|
1.32932e-05
|
|
|
factor v deficiency
|
[NCBI]
|
1.32275e-05
|
|
|
LCT
|
[NCBI]
|
1.28962e-05
|
|
|
mucopolysaccharidosis type ii
|
[NCBI]
|
1.2645e-05
|
|
|
homocystinuria
|
[NCBI]
|
1.24049e-05
|
|
|
OPRM1
|
[NCBI]
|
1.23466e-05
|
|
|
IL4
|
[NCBI]
|
1.20637e-05
|
|
|
MC1R
|
[NCBI]
|
1.1743e-05
|
|
|
RNASE2
|
[NCBI]
|
1.12009e-05
|
|
|
CRC
|
[NCBI]
|
1.10237e-05
|
|
|
XDH
|
[NCBI]
|
1.08407e-05
|
|
|
von willebrand disease
|
[NCBI]
|
1.07522e-05
|
|
|
MDD
|
[NCBI]
|
1.04086e-05
|
|
|
PON1
|
[NCBI]
|
9.99369e-06
|
|
|
CDK4
|
[NCBI]
|
8.75012e-06
|
|
|
CFTR
|
[NCBI]
|
8.38651e-06
|
|
|
PMP22
|
[NCBI]
|
8.33409e-06
|
|
|
FMR1
|
[NCBI]
|
7.80618e-06
|
|
|
TLR2
|
[NCBI]
|
7.64252e-06
|
|
|
RB1
|
[NCBI]
|
7.39641e-06
|
|
|
TG
|
[NCBI]
|
7.1256e-06
|
|
|
NF1
|
[NCBI]
|
6.78548e-06
|
|
|
HDC
|
[NCBI]
|
6.74755e-06
|
|
|
GHR
|
[NCBI]
|
6.69126e-06
|
|
|
TP53
|
[NCBI]
|
6.58077e-06
|
|
|
GTS
|
[NCBI]
|
6.56329e-06
|
|
|
GPI
|
[NCBI]
|
6.11547e-06
|
|
|
BCHE
|
[NCBI]
|
6.05062e-06
|
|
|
TPO
|
[NCBI]
|
5.32854e-06
|
|
|
HP
|
[NCBI]
|
4.08221e-06
|
|
|
PRL
|
[NCBI]
|
3.35287e-06
|
|
|
TS
|
[NCBI]
|
3.34213e-06
|
|
|
PTH
|
[NCBI]
|
2.82669e-06
|
|
|
COMT
|
[NCBI]
|
2.5008e-06
|
|
|
LPL
|
[NCBI]
|
2.34587e-06
|
|
|
NPY
|
[NCBI]
|
2.25119e-06
|
|
|
EGFR
|
[NCBI]
|
2.23198e-06
|
|
|
RNASE3
|
[NCBI]
|
2.09136e-06
|
|
|
POMC
|
[NCBI]
|
2.04777e-06
|
|
|
CF
|
[NCBI]
|
2.00754e-06
|
|
|
TNF
|
[NCBI]
|
1.99712e-06
|
|
|
GAPDH
|
[NCBI]
|
1.78147e-06
|
|
|
HBB
|
[NCBI]
|
1.62241e-06
|
|
|
SHBG
|
[NCBI]
|
1.39752e-06
|
|
|
PCNA
|
[NCBI]
|
1.26117e-06
|
|
|
CD
|
[NCBI]
|
1.17939e-06
|
|
|
ADA
|
[NCBI]
|
1.17719e-06
|
|
|
G6PD
|
[NCBI]
|
5.68227e-07
|
|
|
CEACAM5
|
[NCBI]
|
4.36133e-07
|
|
|
PWS
|
[NCBI]
|
4.0763e-07
|
|
|
VDR
|
[NCBI]
|
3.93097e-07
|
|
|
F3
|
[NCBI]
|
1.60013e-07
|
|
|
MPO
|
[NCBI]
|
8.75674e-08
|
|
|
PD
|
[NCBI]
|
1.33031e-08
|
|